Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection

During hepatitis C virus (HCV) infection, broadly neutralizing antibody (bNAb) responses targeting E1E2 envelope glycoproteins are generated in many individuals. It is unclear if these antibodies play a protective or a pathogenic role during chronic infection. In this study, we investigated whether...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Virol
Autors principals: Swann, Rachael E., Cowton, Vanessa M., Robinson, Mark W., Cole, Sarah J., Barclay, Stephen T., Mills, Peter R., Thomson, Emma C., McLauchlan, John, Patel, Arvind H.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2016
Matèries:
Pathogenesis and Immunity
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4836347/
https://ncbi.nlm.nih.gov/pubmed/26912610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02669-15
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars